Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3Diabetes Mellitus 2Vomiting 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Prostatic Neoplasms 1Premature Birth 1Pre-Eclampsia 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Neoplasms 1Medulloblastoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, B-Cell 1Leiomyosarcoma 1Hyperparathyroidism, Primary 1Hot Flashes 1HER2 IHC3+ Advanced Colorectal Cancer 1Erectile Dysfunction 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1

Interventions

mazdutide 1Tablets 1Sugars 1Standard of Care 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Metformin 1Memantine 1Hormones 1G(M1) Ganglioside 1Exercise 1Donepezil 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cognitive Dysfunction × Tablets × Clear all
NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting
140 enrolled
CNS

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡